Breyna (budesonide/formoterol fumarate MDI) Patient Assistance Program
Don’t let the high cost of brand ICS/LABA MDI disrupt your asthma or COPD treatment. We help eligible patients access Breyna (budesonide and formoterol fumarate MDI) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
Key Takeaways:
- Breyna (budesonide/formoterol fumarate MDI) is FDA-approved as the first generic Symbicort — for treatment of asthma in patients 6 years and older and maintenance treatment of COPD (chronic bronchitis and emphysema). Twice-daily ICS + LABA metered-dose inhaler.
- Without assistance, Breyna costs commonly run approximately $100–$200 per inhaler — significantly less than brand Symbicort.
- Through AffordMyPrescriptions, qualifying patients can access Breyna for a flat $69.95 per month.
- Related product: Symbicort (brand — budesonide/formoterol — same molecules); other generic Symbicort products may be available. Other ICS/LABA combinations: Advair (fluticasone/salmeterol — brand and generic Wixela), Breo Ellipta (once daily), Dulera (mometasone/formoterol). Triple therapy: Trelegy Ellipta, Breztri Aerosphere. SMART regimen (Symbicort/Breyna or Dulera): same ICS/formoterol inhaler as both controller and reliever for asthma. Biologics for severe asthma.
What is Breyna Prescription Assistance Program?
The Breyna Patient Assistance Program helps eligible patients access this generic Symbicort ICS/LABA inhaler at little or no cost when meeting income, insurance, and clinical criteria.
At AffordMyPrescriptions, our Patient Advocates handle the entire Breyna PAP enrollment for a flat $69.95 per month — so you never face a gap in Breyna therapy.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your Breyna enrollment — so you never face a gap in your asthma or COPD maintenance treatment.
Pharmacy Price Comparison
- Breyna is more affordable than brand Symbicort at pharmacies. A Patient Assistance Program can offset costs if you qualify:
| PHARMACY | PRICE (30-DAY) WITH BEST COUPONS | YOU SAVE W/ US |
|---|---|---|
| Wixela (Advair generic) | ~$100/inhaler | Alt generic ICS/LABA |
| Walgreens | ~$150/inhaler | Save substantially |
| CVS Pharmacy | ~$180/inhaler | Save substantially |
| Walmart | ~$120/inhaler | Save substantially |
| Costco | ~$100/inhaler | Save substantially |
| Symbicort brand | ~$400/inhaler | Brand equivalent |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. AffordMyPrescriptions Advocacy Service bypasses pharmacy pricing entirely by using the manufacturer’s assistance program to secure your Breyna — independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Breyna Prescription Program?
The Breyna Patient Assistance Program is free to apply. Our $69.95 per month covers full advocacy. Breyna is the first FDA-approved generic Symbicort — offering significant cost savings vs brand, with comparable efficacy and safety.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for Breyna assistance.
We Advocate
Our specialists gather documentation, complete applications, and coordinate with your prescriber and the assistance program.
Receive Medication
Once approved, your Breyna is delivered through the assistance program while we manage refills and annual renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Breyna:
Limitations of Coupons
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $100–$200 per month even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
If denied, we explore alternative savings paths on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Breyna assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Breyna Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Breyna:
Breyna is the first FDA-approved generic Symbicort — budesonide (ICS) + formoterol (LABA) metered-dose inhaler. Same molecules and delivery as brand Symbicort at significantly lower cost. For asthma and COPD maintenance.
How It Works:
Asthma and COPD both involve airway inflammation and bronchoconstriction. ICS/LABA combinations are the foundation of maintenance therapy for moderate-severe asthma and for COPD patients with frequent exacerbations. Budesonide/formoterol (Symbicort brand; now Breyna generic) is one of the most-prescribed ICS/LABA combinations globally. Budesonide is an inhaled corticosteroid that reduces airway inflammation. Formoterol is a long-acting beta-agonist with rapid onset (unlike salmeterol) — providing bronchodilation and additionally serving as reliever in the SMART regimen for asthma. Breyna delivers the same active ingredients as Symbicort at generic pricing.
Form and Use:
Breyna metered-dose inhaler. Twice daily. Adult and pediatric strengths available. Shake canister before use. Prime as needed per prescribing information. Rinse mouth after use. Not for acute bronchospasm.
Generic Availability:
Breyna is the first FDA-approved generic Symbicort. Brand Symbicort remains available. Other generic Symbicort products may be available. Other ICS/LABA combinations: Advair (fluticasone/salmeterol — generic Wixela; generic HFA available — significantly cheaper), Breo Ellipta (fluticasone furoate/vilanterol — brand once daily), Dulera (mometasone/formoterol — brand). Triple therapy ICS/LAMA/LABA: Trelegy Ellipta, Breztri Aerosphere. Biologics for severe asthma. Asthma and Allergy Foundation of America; COPD Foundation resources.
Warnings:
Asthma-related death (BOXED WARNING historically for LABA monotherapy in asthma — Breyna contains ICS so this is mitigated), oropharyngeal candidiasis (rinse mouth), immunosuppression, hypercorticism and adrenal suppression at high doses, decreased bone mineral density (long-term), glaucoma and cataracts (long-term), cardiovascular effects (LABA), tremor, hypokalemia, hyperglycemia, decreased growth velocity in children, paradoxical bronchospasm, immediate hypersensitivity reactions. Other: nasopharyngitis, headache, oral candidiasis. Not for acute bronchospasm (though formoterol is used in the SMART regimen for asthma).
FAQ (Frequently Asked Questions)
How much does Breyna cost without insurance?
$100–$200 per inhaler at retail pharmacies — significantly less than brand Symbicort (~$400 per inhaler). The first FDA-approved generic Symbicort offers major cost savings.
How is Breyna different from Symbicort?
Breyna is the first FDA-approved generic Symbicort — same active ingredients (budesonide + formoterol) in a metered-dose inhaler at generic pricing. FDA-approved for bioequivalence to brand Symbicort. Comparable efficacy and safety, with significant cost savings.
Can Breyna be used in the SMART regimen for asthma?
Yes — SMART (Single Maintenance And Reliever Therapy) uses an ICS/formoterol combination as both controller and reliever for asthma. Formoterol’s rapid onset makes this feasible. GINA guidelines emphasize ICS-containing therapy for all asthma patients; the SMART approach reduces exacerbations vs controller + SABA reliever.
Can Breyna be used for both asthma and COPD?
Yes — FDA-approved for both. Asthma: 6 years and older. COPD: maintenance treatment of chronic bronchitis and emphysema. Different strengths may apply. Discuss with your prescriber.
How is Breyna different from Wixela (Advair generic)?
Both are generic ICS/LABA inhalers. Breyna is budesonide/formoterol (Symbicort generic MDI). Wixela is fluticasone/salmeterol (Advair Diskus generic DPI). Both effective; choice by device preference (MDI vs Diskus), combination preference, SMART applicability (Breyna yes; Wixela no due to salmeterol’s slower onset), and insurance.
Take Control of Your Medication Costs
Generic ICS/LABA offers cost-effective asthma and COPD maintenance therapy. Our advocacy team is ready — $69.95 per month, or free if we cannot help.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.